CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- 4 Option exercise Chief Strategy Officer acquired 4,700 shares (option exercise)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,191 shares (grant or award)
- 4 Planned sale Director sold 10,079 shares at $8.36 ($84,260)
- 4 Option exercise Chief Executive Officer acquired 13,710 shares (option exercise)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 29,735 shares (option exercise)
- 4 Planned sale Director sold 10,349 shares at $7.76 ($80,308)
- 4 Grant or award Director acquired 5,208 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,558 shares (grant or award)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 10,000 shares (option exercise)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 10,000 shares (option exercise)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 14,184 shares (option exercise)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,382 shares (grant or award)
- 4 Planned sale Director sold 10,312 shares at $7.60 ($78,371)
- 4 Open-market sale 10% owner sold 1,000,000 shares at $7.50 ($7,500,000)
- 4 Planned sale Director sold 10,000 shares at $7.54 ($75,400)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 2,430 shares (grant or award)
- 4 Grant or award Director acquired 5,208 shares (grant or award)
- 4 Open-market sale 10% owner sold 19,341 shares at $8.79 ($170,048)
- 4 Open-market sale 10% owner sold 246,018 shares at an average $8.27 ($2,035,625)
- 4 Planned sale Director sold 10,000 shares at $8.10 ($81,000)
Page 4 of 18 · 349 filings